Compare BSM & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSM | TWST |
|---|---|---|
| Founded | 1876 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2015 | 2018 |
| Metric | BSM | TWST |
|---|---|---|
| Price | $13.97 | $76.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $14.00 | ★ $46.88 |
| AVG Volume (30 Days) | 358.3K | ★ 1.6M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.40% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $469,919,000.00 | $376,572,000.00 |
| Revenue This Year | $11.03 | $18.91 |
| Revenue Next Year | $9.63 | $15.07 |
| P/E Ratio | $12.82 | ★ N/A |
| Revenue Growth | 8.35 | ★ 20.32 |
| 52 Week Low | $11.90 | $23.30 |
| 52 Week High | $15.49 | $80.50 |
| Indicator | BSM | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 68.55 |
| Support Level | $13.06 | $41.85 |
| Resistance Level | $14.27 | $80.50 |
| Average True Range (ATR) | 0.26 | 4.77 |
| MACD | 0.04 | 0.60 |
| Stochastic Oscillator | 80.41 | 77.94 |
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests. The company owns mineral interests in approximately 16.9 million gross acres.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.